| Home
> Table
of Contents > Original
/ Research |
| |
| |
Atypical
Meningiomas
Shilpa Waman Joshi*, Anita Shah** |
| |
Twenty one
cases of atypical meningioma were studied in order to understand
the biological behaviour and the influence of the grade of initial
surgical excision on the postoperative course. The meningiomas
were classified as atypical based on the following factors,
high cellularity, pleomorphism, increased mitotic activity more
than 5 mitosis per 10 H.P.F, prominent nucleoli, foci of spontaneous
or geographic necrosis and absence of tumour invasion into the
cortex . The rate of recurrence, recurrence free survival and
median time to recurrence were ascertained. The prognostic significance
of the Simpson grade of surgical excision and tumour location
were also considered. Recurrence free survival and median time
to recurrence were 7.9 and 5 years respectively. Simpson Grade
I resection was possible namely in cerebral convexity neoplasms.
This was the most important factor resulting in a significantly
better clinical course. Variable combinations of different histological
features did not seem to alter the prognosis. As a factor in
predicting the prognosis radiotherapy was not found useful.
|
| |
| INTRODUCTION |
In 1990 Al-Rodhan and Laws published
a historical account of meningiomas and its surgical management.1
The interest in meningiomas has not declined since then.
In 1922 Cushing2 wrote “There is today nothing in
the whole realm of surgery more gratifying than the successful
removal of meningioma with subsequent recovery.”
These words stand true more than 80 years later. Meningiomas
are the most common primary non glial tumours and comprise
13-19% of all primary intracranial tumours.3 The WHO developed
a new comprehensive classification of central nervous
system neoplasms, where meningiomas are regarded as a
heterogeneous group of mesenchymal tumours with three
grades.4 The characteristic morphology of the benign and
malignant tumours has been exhaustively described earlier.
The existence of an intermediate group of meningiomas,
exhibiting less favourable biological behaviour than classic
benign tumours but a relatively more favourable biological
behavior than malignant tumours has been described. They
have been referred to as atypical meningiomas. |
| |
| Material and Methods |
In this retrospective study, 468 operated
cases of meningiomas at the Bombay Hospital Institute
of Medical Sciences, Mumbai,(January 2000 to November
2004) were analyzed. Histological sub typing of these
tumours was done as per the W.H.O. classification.4 The
clinical data, neuroradiological investigations like magnetic
resonance imaging (M.R.I.) , computed tomography (C.T.
Scan) and type of treatment were studied in detail. The
slides were stained with routine haematoxylin and eosin
stains. The recent W.H.O. classification for diagnosing
atypical and anaplastic (malignant) meningiomas appeared
to be the most appropriate and we adopted the following
grading criteria, which included (a)increased mitotic
activity > 5 mitosis per 10 H.P.F (b) increased cellularity
(c) small cells with high nucleo - cytoplasmic ratio (d)
sheeting of tumour cells with loss of typical histological
pattern (e) prominent nucleoli (f) foci of spontaneous
or geographic necrosis and (g) absence of tumour invasion
into cortex in atypical meningiomas. |
| |
World Health Organization (Who)
Classification for Meningiomas
|
WHO I : Meningiomas, with low risk of recurrence and
/ or low risk of aggressive growth.
WHO II : Atypical meningiomas, with increased mitotic
activity or three or more of the following features:
increased cellularity, small cells with high nucleus-to-cytoplasm
ratio, prominent nucleoli, uninterrupted patternless
or sheetlike growth, and foci of spontaneous or geographic
necrosis.
WHO III : Anaplastic (Malignant) meningiomas: exhibit
frank histologic features of malignancy far in excess
of the abnormalities present in atypical meningiomas.
|
| |
| Results |
Out of the 468 cases operated at this
institute, 21(4.48%) were classified as atypical meningiomas,
8 (1.7%) as malignant and the remaining as benign. Tables
1 and 2 highlights the clinical features of atypical meningiomas
including age, sex, site of the tumours, treatment and
history of recurrences. Figs. 1 and 2 show the histologic
features of atypical meningiomas.
Out of the 21 patients, 19 were males
and 2 females (M/F 9/1). The youngest patient at the time
of first surgery was 15 years and the oldest 74 years
(mean 52 years, median 55 years). Signs and symptoms were
present for 4 weeks to 2 years before diagnosis. Symptoms
of raised I.C.T such as headaches, vomiting, seizures
and focal neurological deficits were present.
 |
Fig. 1 : H and E Stain showing nuclear pleomorphism (x 40). |
| |
 |
The parasagittal and parafalcine regions
represented the most common site of tumour (47.6%) followed
by the convexities (33%), posterior fossa (9.5%) and the
olfactory region (9.5%). Thirteen patients underwent total
resection (Simpson Grade I extirpation). The remaining
8 patients were subjected to subtotal resection (Simpson
Grade II extirpation), due to inaccessibility or huge
size of the tumours. One patient who had total resection
of the tumour expired in the immediate postoperative phase.
Radiotherapy was given to 3 patients with total resection
and 1 with subtotal resection. A postoperative follow
up study revealed that 11 patients (52.3%) suffered recurrences
of which 5 had total resection of the tumour and 6 subtotal
resection. The recurrences occurred 1 to 21 years after
surgery. The mean time of first recurrence was after 7.9
years whereas the median time to the first recurrence
was 5 years. The number of recurrences per person varied
from two to five, with a mean of 3. Grossly the tumours
were well defined, grey brown and ranged from 2.5 cms
to 8 cms. Transtitional meningioma constituted the most
common type of tumour (18 cases). The other types included
meningothelial meningioma (1 case) and angioblastic meningioma
(2 cases). In addition to high cellularity and varied
degree of pleomorphism, all cases had > 5 mitosis /
10 H.P.F. One case had papillary pattern. None of the
tumours showed microscopic cerebral invasion.
 |
| |
 |
Fig.2 : H and E Stain showing mitoses and high cellularity. |
|
| |
| Discussion |
Skullerud et al5 regarded high cellularity
as one of the indicators of recurrence of atypical meningiomas.
Jellinger et al6 stated high cellularity and increased
mitotic index might account for recurrence. Necrosis7
has also been regarded as an indicator of recurrence.
The recent W.H.O. classification provides a broader criteria
to differentiate atypical and malignant meningiomas. In
the present study twenty one cases that fulfilled the
W.H.O. criteria were diagnosed as atypical meningiomas
and formed the base of this study. There were 19 males
and 2 females with an average age of 52 years. This is
comparable with previous reports which state that the
male gender was predominant (Thomas et al,8 Sano et al9.
Postoperative follow up showed 11 patients had recurrence
(52.3%) ( W.Y.K. Chen et al10). Median time to the first
recurrence was 5 years and the number of recurrence per
person varied from two to five, with a mean of 3 which
was similar to findings reported by Lucio Palma et al.11
In our study all the cases of atypical meningiomas showed
> 5 mitosis 10 H.P.F., but the number of mitotic figures
per se did not affect the recurrence. We thus share the
same observations with Jellinger et al6 that mitotic rate
alone appears to be of no prognostic value. The recurrence
rate also did not relate to any histological subtype (W.Y.K.
Chen et al.10 )
The completeness of the surgery is the
single most important prognostic factor as brought out
by our study. This is also substantiated by other workers.
(Kinjo et al,12 Borovich et al13). The prognostic influence
of radical surgery in our study is emphasized by the fact
that out of the 7 meningiomas of the convexities 6 had
Simpson Grade I extirpation and 1 Simpson Grade II. The
tumours that were totally resected did not show any recurrence
except one. The one that did recur was after 23 years
of surgery.11 The tumour which had Simpson Grade II extirpation
recurred just after two years of surgery ( Lucio Palma
et al11). Out of the 10 tumours of the parasagittal, parafalcine
and tentorial regions 4 patients had total resection and
6 subtotal resection. 8 of these recurred out of which
5 were resected sub totally. The other 3 recurred even
after supposedly Simpson Grade I extirpation was carried
out. This can be explained by the fact that true Simpson
Grade I extirpation can only be accomplished for tumours
located in the cerebral convexities, and not in the parasagittal
/ parafalcine regions.12,13 Even though both the tumours
situated in the olfactory region were treated by total
resection, 1 recurred due to its large size and involvement
of the surrounding anatomical structures. 1 out of the
2 patients having posterior fossa lesions underwent total
resection and succumbed immediately due to its proximity
to vital structures of the brain. The other who had subtotal
resection did not have any recurrence. Thus it can be
concluded that out of the 13 tumours that were resected
totally 5 showed recurrence. These recurrences could be
explained by the fact that 3 were tumours of the parafalcine/
parasagittal regions, 1 of the orbit12,13 and 1 of the
frontal lobe which recurred only after 23 years of surgery.
Postoperative radiation therapy was used
in 3 patients, who supposedly had total resection of the
tumours. But the tumours recurred in 2 patients because
one had tumour involving the orbit and the surrounding
anatomical structures and the other, the parafalcine region.14
Radiation therapy used in 1 patient who had subtotal resection
for a tentorial based meningioma showed postradiation
recurrence due to incomplete removal of the tumour |
| |
| Conclusion |
The following conclusions emerge from the present study.
The recurrence rate for the tumours of the convexity was
low as compared to that of the other regions. This is explained
by the fact that these tumours were easily accessible and
could be completely resected. Thus the site of tumour and
the type of surgery were the two most important factors
in the prognosis of the atypical meningiomas. Variable combinations
of different histological features did not seem to alter
the prognosis. As a factor in predicting the prognosis of
atypical meningiomas radiotherapy was not discriminatory. |
| |
| Acknowledgements |
| We express thanks to Dr. Arun Chitale, Professor and Head
Department of Pathology, for permitting us to publish the
data. |
| |
References
| 1. |
Al-Rodhan NRF,
Laws Junior, et al. Meningioma: a historical study
of the tumor and its surgical management. Neurosurgery
1990; 26 : 832-47. |
| 2. |
Cushing H. The
Meningiomas ( dural endothelioma): their source
and favored seats of origin. Brain 1992; 45: 282-316. |
| 3. |
Russell DS, Rubenstein
LJ. Pathology of tumors of the nervous system, 5th
ed. Baltimore: Williams and Wilkins, 1989. |
| 4. |
WHO 2000 Classification
of Meningiomas. |
| 5. |
Skullerud K, Loken
AC. The prognosis in meningioma. Acta Neuropathol
(Berl) 1974; 29 : 337-44. |
| 6. |
Jellinger K, Slowik
F. Hitologic subtypes and prognostic problems in
meningioma. J Neurol 1975; 208 : 279-98. |
| 7. |
Christensen D, Laursen H, Klinken L.
Prediction of recurrence in meningiomas after surgical
treatment. Acta Neuropathol (Berl) 1983; 61 : 130-34.
|
| 8. |
Thomas HG, Dolman,
et al. Malignant Meningioma: clinical and pathological
features. J Neurosurg 1981; 55 : 929-34. |
| 9. |
San K. A statistical
study of brain tumors in Japan, general features.
Jpn J Clin Oncol 1987; 17 : 19-28. |
| 10. |
Chen WYK, Liu
HC. Atypical Meningioma: relationship between histologic
features and recurrence. Clin Neuropath 1990; 9
(2) : 74-81 |
| 11. |
Lucio Palma, et
al. Long term prognosis for atypical and malignant
meningiomas: a study of 71 surgical cases. J Neurosurgery
1997; 86 : 793-800. |
| 12 |
Kinjo J, Al-Mefty
et al.Grade zero removal of supratentorial convexity
meningiomas. Neurosurgery 1993; 33 : 394-99. |
| 13. |
Borovich B, Doron
Y, et al. Recurrence of intracranial meningiomas:
the role played by regional multicentricity, Part
2: Clinical and radiological aspects. J Neurosurgery
1986; 85 : 168-71. |
| 14. |
Jaaskalainen
J, Haltia M, et al. Atypical and anaplastic meningiomas:
Radiology, surgery, radiotherapy and outcome. Surg
Neurol 1986; 25 : 233-42. |
| |
|
|
MASS,
SINGLE-DOSE TREATMENT TO PERVENT TRACHOMA
Trachoma, an important cause
of blindness, is caused by infection with Chlamydia
trachomatis. In a Tanzanian community in which
trachoma was endemic, the residents each received
a single dose of azithromycin. After 24 months,
the infection had virtually been eradicated from
the community.
N Engl J Med 2004;351
: 1962
USE ACE INHIBITORS IN PATIENTS WITH DIABETIC NEPHROPATHY
Angiotensin converting enzyme (ACE) inhibitors may be the best choice for patients with diabetic nephropathy. Reviewing 43 trials. Strippoli and colleagues found that ACE inhibitors, but notangiotensin II receptor antagonists, improved survival of these patients. The drugs had a similar effect on renal function. Because of the lack of good quality trials, the relative effects of ACE inhibitors and angiotensin II receptor blockers on survival is not known.
BMJ, 2004; 329 : 828.
|
|
|
*Ex lecturer, Department of Pathology, Grant Medical College and Sir J.J Group of Hospitals, Mumbai.
**Honorary Associate Consultant Pathologist, Bombay Hospital Institute of Medical Sciences, Mumbai.
|
|
|